Novel biomarker tests have met or exceeded the performance of common lab tests for diagnosing nonalcoholic steatohepatitis (NASH, now known as metabolic dysfunction-associated steatohepatitis or MASH) ...

An intelligent liver function test platform (iLFT) successfully integrated into one Scottish primary care system reduced unnecessary specialist referrals over a 5-year period, and improved triage for ...

Researchers have recently created a blood test that can detect liver disease years before symptoms ever develop, helping pave the way for the diagnosis of diseases such as cirrhosis and liver cancer ...

Cirrhosis and liver cancer are two of the world’s leading causes of illness and death, but they typically creep up quietly. Most people with liver disease are symptom-free until complications like ...

Researchers from Mass General Brigham, Harvard T.H. Chan School, and the Broad Trauma Initiative have identified 16 common blood biomarkers connected to PTSD across multiple organ systems. The study, ...

Researchers at the Yale Liver Center found that patients with COVID-19 presented with abnormal liver tests at much higher rates than suggested by earlier studies. They also discovered that higher ...

Research from the Medical University of South Carolina's Digestive Disease Research Core Center suggests that physicians can fail to diagnose alcoholic cirrhosis if they rely solely on laboratory test ...

A US biotechnology company has 3D printed a tiny functioning liver in the lab that survived just over five days -- more than twice the life expectancy of 2D versions. Presenting the results at the ...

A groundbreaking new screening tool can detect the source of a silent killer using routine blood tests all without asking the patient a single question. A primary driver of fatty liver disease is ...